New Article! Impact of Medicaid Expansion on Timely Cancer Treatment
Previous racial disparities in timely cancer treatment between African-American and white patients practically disappeared in states where Medicaid access was expanded under the Affordable Care Act (ACA), according to a new analysis of electronic health records of over 30,000 patients.
Dr. Maria-Victoria Mateos discusses findings from the Phase 3 COLUMBA study and impact on patient care.
New Video! Impact of CASSIOPEIA Study
Dr. Philippe Moreau reveals data from the Phase 3 CASSIOPEIA study and its impact on patient care.
Iberdomide in Combo With Dexamethasone In Patients With Relapsed/Refractory Multiple Myeloma
The first clinical results evaluating iberdomide (CC-220) in combination with dexamethasone in patients with relapsed and refractory multiple myeloma from the ongoing phase I/II CC-220-MM-001 study were released during an oral presentation at the 2019 ASCO Annual Meeting.